|
- Subcutaneous Injection | OPDIVO® (nivolumab) + Qvantig™ (hyaluronidase . . .
Learn more about OPDIVO® (nivolumab) + Qvantig™ (hyaluronidase-nvhy) as a subcutaneous injection treatment option for your fight against cancer Please see Indication and Important Safety Information
- OPDIVO® (nivolumab)
OPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer Read the indications, side effects, and more Please see Indication and Important Safety Information
- How This Treatment Works | OPDIVO® (nivolumab)
Learn how OPDIVO® (nivolumab) alone and OPDIVO® + YERVOY® (ipilimumab) in combination work with your immune system to fight cancer Ask your doctor if these immunotherapies may work for you Access treatment information for your cancer type
- Advanced PD-L1 Positive NSCLC | Clinical Trial Results |OPDIVO . . .
See how OPDIVO® (nivolumab) + YERVOY® (ipilimumab) performed in a clinical trial as first-line treatment for adults with advanced non-small cell lung cancer that tested positive for PD-L1 Please see Indication and Important Safety Information
- about side effects - OPDIVO
Learn more about the potential and most common side effects of OPDIVO® (nivolumab) Access side effect information for OPDIVO® (nivolumab) or an OPDIVO®-based combination immunotherapy Please see Indication and Important Safety Information
- Financial Information: Cost, Access Affordability - OPDIVO
This is a summary of important information that you need to know about OPDIVO and OPDIVO + YERVOY Your healthcare team can work with you to help answer any questions you may have about these medications
- Previously Treated Advanced Bladder or Urinary Tract Cancer . . . - OPDIVO
See how OPDIVO® (nivolumab) performed in a clinical trial as a treatment for certain adults with previously treated advanced bladder or urinary tract cancer, or urothelial carcinoma Please see Indication and Important Safety Information
- Frequently Asked Questions (FAQ) | OPDIVO® (nivolumab)
Find answers to frequently asked questions about OPDIVO® (nivolumab) including what OPDIVO® is, how immunotherapy works, and what are the side effects of OPDIVO® Please see Indication and Important Safety Information
|
|
|